Exact Mass: 722.2322928

Exact Mass Matches: 722.2322928

Found 80 metabolites which its exact mass value is equals to given mass value 722.2322928, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Kansuinine B

[(1S,3S,4S,6S,9R,10S,12R,13S,14R,15R,16S)-1,14-diacetyloxy-10-benzoyloxy-9,15,16-trihydroxy-3,7,7,15-tetramethyl-11-methylidene-2,8-dioxo-5-oxatricyclo[11.3.0.04,6]hexadecan-12-yl] benzoate

C38H42O14 (722.2574432)


Kansuinine B is a benzoate ester. Kansuinine B is a natural product found in Euphorbia kansui with data available.

   

Citbismine D

12-[5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-1-yl]-7,11-dihydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C40H38N2O11 (722.2475478000001)


Citbismine D is found in citrus. Citbismine D is an alkaloid from roots of Marsh grapefruit (Citrus paradisi). Alkaloid from roots of Marsh grapefruit (Citrus paradisi). Citbismine D is found in citrus.

   
   

8)-eriodictyol

5-O-beta-D-Glucosylluteoliflavan-(4-

C36H34O16 (722.1846764000001)


   
   
   
   

6-(3-Hydroxy-3-methylglutaroyl)isoviolanthin

6-(3-Hydroxy-3-methylglutaroyl)isoviolanthin

C33H38O18 (722.2058048)


   
   

Formononetin 7-O-(2,6-di-O-(E-p-coumaroyl)glucoside)

7-Hydroxy-4-methoxyisoflavone 7-O-(2,6-di-O-E-p-coumaroyl)-glucoside

C40H34O13 (722.1999314)


   
   

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate

C34H42O17 (722.2421882000001)


   

[(2S,3R,4R,5S,6S)-2-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-6-methyloxan-3-yl] (E)-3-phenylprop-2-enoate

[(2S,3R,4R,5S,6S)-2-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-6-methyloxan-3-yl] (E)-3-phenylprop-2-enoate

C34H42O17 (722.2421882000001)


   

5-O-beta-D-Glucosylluteoliflavan-(4->8)-eriodictyol

5-O-beta-D-Glucosylluteoliflavan-(4->8)-eriodictyol

C36H34O16 (722.1846764000001)


   
   

2,4-di-O-acetyl-3-O-methylverbascoside

2,4-di-O-acetyl-3-O-methylverbascoside

C34H42O17 (722.2421882000001)


   

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-2,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-2,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

C33H38O18 (722.2058048)


   

jaspamide D

jaspamide D

C37H47BrN4O6 (722.2678782)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.

   

dihalenaquinolide B

dihalenaquinolide B

C44H34O10 (722.2151864)


   

Me glycoside,hepta-Ac-beta-Pyranose-Xylotriose

Me glycoside,hepta-Ac-beta-Pyranose-Xylotriose

C30H42O20 (722.2269332000001)


   
   

24-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotetraose

24-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotetraose

C26H42O23 (722.2116782)


   

O-beta-D-xylopyranosyl-(1<*>4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose

O-beta-D-xylopyranosyl-(1<*>4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose

C30H42O20 (722.2269332000001)


   
   
   

aeruginosin DA722|D-o,o-di-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine

aeruginosin DA722|D-o,o-di-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine

C29H44Cl2N6O9S (722.2267394)


   

6-O-alpha-L-(2-O-trans-cinnamoyl-3-O-isovaleryl)rhamnopyranosylcatalpol|gmelinoside M

6-O-alpha-L-(2-O-trans-cinnamoyl-3-O-isovaleryl)rhamnopyranosylcatalpol|gmelinoside M

C35H46O16 (722.2785716)


   

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-3,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-3,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

C33H38O18 (722.2058048)


   
   

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-4,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-4,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside

C33H38O18 (722.2058048)


   
   
   

jaspamide G

jaspamide G

C36H43BrN4O7 (722.2314948000001)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.

   

Scirpusin A-hexaacetat

Scirpusin A-hexaacetat

C40H34O13 (722.1999314)


   

C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,3-Di-O-acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

NCGC00169152-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,3-Di-O-acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

C34H42O17 (722.2421882000001)


   

C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,4-Di-O-acetyl-6-deoxy-3-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

NCGC00179976-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,4-Di-O-acetyl-6-deoxy-3-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

C34H42O17 (722.2421882000001)


   

C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({3,4-Di-O-acetyl-6-deoxy-2-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

NCGC00169427-03_C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({3,4-Di-O-acetyl-6-deoxy-2-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

C34H42O17 (722.2421882000001)


   
   

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_6.1\\%

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_6.1\\%

C34H42O17 (722.2421882000001)


   

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_major

[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_major

C34H42O17 (722.2421882000001)


   
   
   
   
   
   
   
   

Amorphol

Amorphigenol O-vicianoside

C34H42O17 (722.2421882000001)


   

Citbismine D

12-[5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-1-yl]-7,11-dihydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C40H38N2O11 (722.2475478000001)


   
   
   

2-[3-[1,1-Dimethyl-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-propenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt

2-[3-[1,1-Dimethyl-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-propenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt

C39H43N2NaO6S2 (722.2460098000001)


   

Obicetrapib

Obicetrapib (AMG-899,TA-8995)

C32H31F9N4O5 (722.2150624)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

(R)-(+)-5,5-Bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole,min.98(R)-DM-SEGPHOS

(R)-(+)-5,5-Bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole,min.98(R)-DM-SEGPHOS

C46H44O4P2 (722.2714684)


   

Brostallicin

Brostallicin

C30H35BrN12O5 (722.20366)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

(+)-Jasplakinolide W

(+)-Jasplakinolide W

C36H43BrN4O7 (722.2314948000001)


A cyclodepsipeptide isolated from Jaspis splendens.

   
   

jaspamide B

jaspamide B

C36H43BrN4O7 (722.2314948000001)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.

   

Jasplakinolide D

Jasplakinolide D

C37H47BrN4O6 (722.2678782)


A cyclodepsipeptide isolated from Jaspis splendens.

   

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C37H46N4O7S2 (722.2807766000001)


   

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C37H46N4O7S2 (722.2807766000001)


   

5-[(1S,2R)-5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1,2-dihydrofuro[2,3-c]acridin-1-yl]-6,10-dihydroxy-11-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one

5-[(1S,2R)-5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1,2-dihydrofuro[2,3-c]acridin-1-yl]-6,10-dihydroxy-11-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one

C40H38N2O11 (722.2475478000001)


   

6-({8-[3,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({8-[3,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H34O16 (722.1846764000001)


   

[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4R,5S)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate

[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4R,5S)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate

C30H42O20 (722.2269332000001)


   

[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4S,5R)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate

[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4S,5R)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate

C30H42O20 (722.2269332000001)


   

Naloxonazine (dihydrochloride)

Naloxonazine (dihydrochloride)

C38H44Cl2N4O6 (722.2637744000001)


Naloxonazine dihydrochloride is a specific μ-opioid receptor antagonist with an IC50 of 5.4 nM. Naloxonazine dihydrochloride also shows anti-leishmanial activity[1][2][3].

   

NGR peptide (Trifluoroacetate)

NGR peptide (Trifluoroacetate)

C22H37F3N10O10S2 (722.2087538000001)


NGR peptide Trifluoroacetatecontaining the Asn-Gly-Arg (NGR) motif. NGR peptide Trifluoroacetate binds to APN/CD13. NGR peptide Trifluoroacetate is directly conjugated to imaging agents that can be used for tumor imaging[1][2].

   

(1s,3r,4s,6s,9r,10s,12r,13s,14r,15s,16s)-14,16-bis(acetyloxy)-12-(benzoyloxy)-1,9,15-trihydroxy-3,7,7,15-tetramethyl-11-methylidene-2,8-dioxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-10-yl benzoate

(1s,3r,4s,6s,9r,10s,12r,13s,14r,15s,16s)-14,16-bis(acetyloxy)-12-(benzoyloxy)-1,9,15-trihydroxy-3,7,7,15-tetramethyl-11-methylidene-2,8-dioxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-10-yl benzoate

C38H42O14 (722.2574432)


   

(1s,2s,4s,7r,9r,11s,13r,14s,15r,16s,17r)-15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

(1s,2s,4s,7r,9r,11s,13r,14s,15r,16s,17r)-15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

C35H46O16 (722.2785716)


   

2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

C35H46O16 (722.2785716)


   

4,22-dimethyl (1s,4s,5r,6s,7r,8r,10s,14s,16r,18s,19r,22s,23r,25s,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6-methyl-25-[(2-methylbutanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4,22-dicarboxylate

4,22-dimethyl (1s,4s,5r,6s,7r,8r,10s,14s,16r,18s,19r,22s,23r,25s,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6-methyl-25-[(2-methylbutanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4,22-dicarboxylate

C35H46O16 (722.2785716)


   

7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,17,19-pentamethyl-15-methylidene-1-oxa-5,8,11-triazacyclononadeca-5,11-diene-2,9,16-trione

7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,17,19-pentamethyl-15-methylidene-1-oxa-5,8,11-triazacyclononadeca-5,11-diene-2,9,16-trione

C36H43BrN4O7 (722.2314948000001)


   

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{[(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-{2-[(2s)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-4-hydroxyphenoxy}-5-hydroxy-6-methyloxan-4-yl]oxy}-3,4-dihydroxyoxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{[(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-{2-[(2s)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-4-hydroxyphenoxy}-5-hydroxy-6-methyloxan-4-yl]oxy}-3,4-dihydroxyoxan-2-yl]methyl acetate

C33H38O18 (722.2058048)


   

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (1s,4as,7r,7ar)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (1s,4as,7r,7ar)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C31H46O19 (722.2633166)


   

(2s,3r,4r,5s,6s)-3,5-bis(acetyloxy)-2-{[(1s,2s,4s,5s,6s,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate

(2s,3r,4r,5s,6s)-3,5-bis(acetyloxy)-2-{[(1s,2s,4s,5s,6s,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate

C34H42O17 (722.2421882000001)